Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02661009
What this trial is testing

Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method)

Who this might be right for
Non Small Cell Lung CancerEGFR-TKI Resistant MutationEGFR-TKI Sensitizing Mutation
GenoSaber 1,000
Very early researchUnknownNCT06060964
What this trial is testing

Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Stage ILung Cancer Stage II+1 more
University of South Carolina 24
Not applicableEnrolling By InvitationNCT01385722
What this trial is testing

Molecular Analysis of Thoracic Malignancies

Who this might be right for
Thymus CancerThymomaThymic Carcinoma+3 more
Stanford University 1,000
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT03141957
What this trial is testing

Hypermetabolism in the Elderly Lung Cancer Patient

Who this might be right for
Non-small Cell Lung Carcinoma
University of Paris 5 - Rene Descartes 27
Testing effectiveness (Phase 2)WithdrawnNCT02044601
What this trial is testing

Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Not applicableUnknownNCT02804100
What this trial is testing

Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell LungBronchial NeoplasmsCarcinoma, Bronchogenic+2 more
Wenzhou Medical University 200
Not applicableUnknownNCT03066271
What this trial is testing

Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer StageChemoradiation
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05853575
What this trial is testing

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07438600
What this trial is testing

Study of Sacituzumab Tirumotecan Combined With Toripalimab for Resectable Stage II-IIIB NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital 38
Early research (Phase 1)UnknownNCT03050411
What this trial is testing

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07355231
What this trial is testing

Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Xemed LLC 10
Large-scale testing (Phase 3)Study completedNCT03515837
What this trial is testing

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 492
Not applicableEnded earlyNCT02671045
What this trial is testing

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small Cell Lung
Cota Inc. 649
Testing effectiveness (Phase 2)Ended earlyNCT02257619
What this trial is testing

Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 9
Not applicableLooking for participantsNCT07486219
What this trial is testing

Magnetic Resonance Imaging of the Lung: Oncological Applications

Who this might be right for
Lung Cancer (NSCLC)
Fondazione IRCCS Policlinico San Matteo di Pavia 50
Testing effectiveness (Phase 2)WithdrawnNCT03684967
What this trial is testing

Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC

Who this might be right for
Lung Cancer
Hutchison Medipharma Limited
Large-scale testing (Phase 3)Study completedNCT01631136
What this trial is testing

Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 932
Large-scale testing (Phase 3)Study completedNCT00002911
What this trial is testing

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
ILEX Oncology Services, Incorporated
Next Page